P/E ratio for uniQure (QURE)

P/E ratio history for uniQure from 2014 to 2023

PE ratio at the end of each year

P/E ratio for similar companies or competitors

Company	P/E ratio	P/E ratio differencediff.	Country
Amgen AMGN	19.7	-1,186.06%	🇺🇸 USA
Sangamo Therapeutics SGMO	-1.64	-9.44%	🇺🇸 USA
bluebird bio BLUE	-0.4089	-77.40%	🇺🇸 USA
Avidity Biosciences RNA	-13.3	636.20%	🇺🇸 USA
Sanofi SNY	15.1	-933.35%	🇫🇷 France
BioMarin Pharmaceutical BMRN	83.5	-4,715.72%	🇺🇸 USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.